Maravai Lifesciences Holdings (MRVI) Other Working Capital Changes (2020 - 2025)
Maravai Lifesciences Holdings (MRVI) posted quarterly Other Working Capital Changes of -$203000.0 for Q1 2026, up 97.61% year-over-year from -$102728.1 in Q1 2025, and up 89.28% quarter-over-quarter from -$1.9 million in Q4 2025.
Analysis
Maravai Lifesciences Holdings (MRVI) Other Working Capital Changes (2020 - 2025) Analysis & Trends
Maravai Lifesciences Holdings' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$203000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 97.61% year-over-year to -$203000.0; the TTM figure through Mar 2026 stood at -$10.3 million (up 24.16% YoY), while the FY2025 annual figure was -$18.6 million, down 195.78% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$203000.0, up from -$1.9 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $26.3 million in Q3 2022, with the low at -$21.3 million in Q2 2023.
- The 5-year median for Other Working Capital Changes is -$439000.0 (2024), against an average of $2.0 million.
- Peak annual rise in Other Working Capital Changes reached 12217.19% in 2025, while the deepest fall reached 638.26% in 2025.
- Maravai Lifesciences Holdings' Other Working Capital Changes stood at -$2.7 million in 2022, then soared by 40.04% to -$1.6 million in 2023, then increased by 29.88% to -$1.2 million in 2024, then tumbled by 64.61% to -$1.9 million in 2025, then surged by 89.28% to -$203000.0 in 2026.
- Business Quant data shows MRVI's Other Working Capital Changes at -$203000.0 in Q1 2026, -$1.9 million in Q4 2025, and -$16.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Maravai Lifesciences Holdings | 1.09 Bn | 1.02 Bn | 20.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -1.12 Mn |
| Jun 30, 2025 | -1.12 Mn |
| Mar 31, 2025 | 381,000.00 |
| Mar 31, 2025 | 381,000.00 |
| Dec 31, 2024 | 472,000.00 |
| Dec 31, 2024 | 472,000.00 |
| Sep 30, 2024 | -244,000.00 |
| Sep 30, 2024 | -244,000.00 |
| Jun 30, 2024 | -64,000.00 |
| Jun 30, 2024 | -64,000.00 |
| Mar 31, 2024 | -1.15 Mn |
| Mar 31, 2024 | -1.15 Mn |
| Dec 31, 2023 | 808,000.00 |
| Dec 31, 2023 | 808,000.00 |
| Sep 30, 2023 | 94,000.00 |
| Sep 30, 2023 | 94,000.00 |
| Jun 30, 2023 | 406,000.00 |
| Jun 30, 2023 | 406,000.00 |
| Mar 31, 2023 | -1.06 Mn |
| Mar 31, 2023 | -1.06 Mn |